[ Price : $8.95]
FDAs New Jersey District Office releases an FDA-483 detailing eight violations found at Integra LifeSciences.[ Price : $8.95]
FDA says it will review an Onyx NDA for carfilzomib to treat some patients with multiple myeloma.[ Price : $8.95]
FDA releases an FDA-483 detailing 10 inspectional observations made at Zimmer, Inc.[ Price : $8.95]
A news report says Ranbaxy Laboratories is close to resolving data integrity and quality control issues involving its generic drug...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on use of nucleic acid tests on pooled and individual samples from blood do...[ Price : $8.95]
FDA approves a Mylan ANDA for a generic copy of Pharmacia & Upjohns chemoprotective agent Zinecard.[ Price : $8.95]
Takeda files an NDA for alogliptin/metformin, a fixed-dose combination therapy for treating patients with Type 2 diabetes.[ Price : $8.95]
The Washington Legal Foundation says Par Pharmaceuticals has a good chance of prevailing in its recent First Amendment suit agains...